Moreover, CAR-T cells derived from CD4+ naïve T cells (TN) cells of CLL patients show the inferior ability of expansion and express a higher level of PD-1 than healthy individuals [72]. The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.